Nonin Medical develops cerebral oximeter

1 August 2008

Nonin Medical has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Today's most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain — cerebral oximetry.

The company says that early testing data and outcomes from an ongoing clinical study at the Duke University Medical Center have yielded favourable results. The results support the objective to simplify sensor application while improving the usefulness of the measurement.

For over two decades, Nonin Medical has developed products for noninvasive physiological monitoring, with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx, the world's first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Today, Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide.

"This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again," said Gary Tschautscher, CEO and President of Nonin Medical.

"We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions. Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives."

The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems. This aligns with Nonin Medical's vision for interoperability and facilitating information flow without the need of proprietary interfaces.

"We must leave the old business models of protectionism behind," said Tschautscher. "This is one reason why Nonin Medical is actively supporting and driving open communication standards."

Earlier this year Nonin introduced a fingertip oximeter with Bluetooth wireless technology. The Onyx II, Model 9560 fingertip pulse oximeter is designed for interoperability, meeting the requirements of the emerging Medical Device Profile (MDP), IEEE11073 and Continua compliance standards. The technology enables vital signs to be easily monitored by the patient and sent wirelessly through communication devices such as cell phones, PDAs, PCs, etc. See MTB Europe story: Nonin introduces Bluetooth wireless fingertip pulse oximeter

Your browser does not support inline frames or is currently configured not to display inline frames.	Your browser does not support inline frames or is currently configured not to display inline frames. Nonin Medical develops cerebral oximeter 1 August 2008 Nonin Medical has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Today's most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain — cerebral oximetry. The company says that early testing data and outcomes from an ongoing clinical study at the Duke University Medical Center have yielded favourable results. The results support the objective to simplify sensor application while improving the usefulness of the measurement. For over two decades, Nonin Medical has developed products for noninvasive physiological monitoring, with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx, the world's first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Today, Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide. "This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again," said Gary Tschautscher, CEO and President of Nonin Medical. "We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions. Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives." The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems. This aligns with Nonin Medical's vision for interoperability and facilitating information flow without the need of proprietary interfaces. "We must leave the old business models of protectionism behind," said Tschautscher. "This is one reason why Nonin Medical is actively supporting and driving open communication standards." Earlier this year Nonin introduced a fingertip oximeter with Bluetooth wireless technology. The Onyx II, Model 9560 fingertip pulse oximeter is designed for interoperability, meeting the requirements of the emerging Medical Device Profile (MDP), IEEE11073 and Continua compliance standards. The technology enables vital signs to be easily monitored by the patient and sent wirelessly through communication devices such as cell phones, PDAs, PCs, etc. See MTB Europe story: Nonin introduces Bluetooth wireless fingertip pulse oximeter Your browser does not support inline frames or is currently configured not to display inline frames. To top	Your browser does not support inline frames or is currently configured not to display inline frames.